Executive Summary
Rating: HOLD | LASR
I would put my rating as a Hold because nLIGHT’s revenue is accelerating, but the stock already discounts a much cleaner earnings path than the current margin profile supports. Revenue reached $80.2M in Q1 2026, up 55.2% year over year, yet TTM operating margin was still -53.0% and FCF yield was only 0.7%, so the market is paying for a profit inflection that has not fully arrived. I would move from Hold to Buy if revenue stays above $80M for two more quarters and operating margin turns positive, meaning the core business is covering fixed costs rather than just growing the top line.
Company Profile
nLIGHT designs and manufactures high-power semiconductor lasers, fiber lasers, fiber amplifiers, and beam-combining systems used in directed-energy, laser-sensing, industrial, and microfabrication equipment. It sells into Aerospace and Defense, Industrial, and Microfabrication through two segments: Laser Products and Advanced Development, the latter focused on next-generation directed-energy and sensing technologies for government programs. The company serves more than 300 customers worldwide and manufactures in Camas and Vancouver, Washington; Hillsboro, Oregon; Longmont, Colorado; and Lohja, Finland, with contract packaging in Thailand. It is listed on Nasdaq under LASR and had more than 800 full-time employees at December 31, 2025.
Economic Moat
Business Model
In my view, nLIGHT’s most defensible asset is its patented multiplexed single-chip architecture, which combines multiple laser chips into a brighter commercial semiconductor laser and is hard to replicate quickly because it depends on design, packaging, and qualification know-how built over time. The company also controls semiconductor chips, optical fiber, and beam-combining systems in-house, which shortens design cycles and protects proprietary manufacturing steps. That vertical integration is consistent with the 31.3% gross margin in the TTM data, but the -0.5% operating margin shows the moat is still being monetized unevenly.
Business & Operating Risks
Competition is a high-severity risk because nLIGHT faces significant price and technology pressure from larger rivals with deeper manufacturing, financial, and R&D resources. The risk factors also point to customer concentration, since the company relies on a small number of customers for a meaningful share of revenue and does not have long-term purchase commitments. Government-program exposure adds another layer of risk: awards can be delayed, protested, modified, or terminated for convenience, and unsettled incurred-cost claims can slow billing and create repayment or penalty exposure.
Management Discussion & Analysis
Management is clearly leaning into Aerospace and Defense, where revenue rose to $175.3M in FY2025 from $109.5M in FY2024, and that mix shift is the clearest evidence that directed-energy programs are now the main growth engine. According to management’s discussion in the 10-K, Laser Products gross margin improved to 39.2% in FY2025 from 22.8% in FY2024 because of higher directed-energy sales, better fixed-cost absorption, and improved yields. I read that as proof that the operating model can scale, but only if defense demand remains steady enough to keep the factory loaded.
Recent Earnings
The latest quarter shows the moat being tested, not broken. EBITDA improved to $4.4M in Q1 2026 from $-4.2M in Q1 2025, and net income turned positive at $0.6M, which tells me the product mix is finally helping absorb fixed costs. The quarter also matters because the company is still carrying a large manufacturing footprint across five sites plus Thailand, so the current earnings improvement has to continue before I would call it durable.
Financial Analysis
Growth
LASR — Financial Growth (Quarterly, USD Mil)
| Metric | 2025-03-31 | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|---|
| REVENUE (USD Mil) | 51.7 | 61.7 | 66.7 | 81.2 | 80.2 |
| EBIT (USD Mil) | -7.9 | -3.2 | -6.3 | -4.3 | 1 |
| EBITDA (USD Mil) | -4.2 | 0.2 | -3 | -0.4 | 4.4 |
| NET INCOME (USD Mil) | -8.1 | -3.6 | -6.9 | -4.9 | 0.6 |
| DILUTED EPS | -0.2 | -0.1 | -0.1 | -0.1 | 0 |
Source: Yahoo Finance — Quarterly Financial Statements
Revenue rose from $51.7M in Q1 2025 to $80.2M in Q1 2026, a 55.2% increase that is strong enough to show real demand momentum. EBITDA moved from $-4.2M to $4.4M over the same period, which is the more important signal because it shows growth is starting to convert into operating leverage rather than just volume. Net income also crossed into the black at $0.6M, but I would treat that as an early milestone, not proof of a sustained earnings base.
Profitability
LASR — Profitability (TTM)
| Metric | TTM |
|---|---|
| Operating Margin (TTM) | -0.5% |
| Net Margin (TTM) | -5.1% |
| Return on Assets (TTM) | -2.3% |
| Return on Equity (TTM) | -4.6% |
| Gross Margin (TTM) | 31.3% |
| EBITDA Margin (TTM) | -0.4% |
Source: Yahoo Finance — Trailing Twelve Months (TTM)
TTM gross margin was 31.3%, while operating margin was -0.5% and EBITDA margin was -0.4%, so the product layer is healthy but overhead is still close to swallowing the gross profit. Net margin was -5.1%, return on assets was -2.3%, and return on equity was -4.6%, which tells me the company is still in the early part of the earnings conversion curve. The key link to the moat is simple: the patented platform can support better economics, but until operating margin turns positive, the advantage is not yet flowing through the income statement.
Valuation
LASR — Valuation Multiples
| Metric | Value |
|---|---|
| Market Cap (USD Mil) | 3,462 |
| Enterprise Value (USD Mil) | 3,165 |
| Forward P/E | 90.8 |
| Price/Sales (TTM) | 11.9 |
| Price/Book (mrq) | 8.1 |
| EV/Revenue | 10.9 |
| EV/EBITDA | -2,985.7 |
| Beta (5Y Monthly) | 2.29 |
| FCF Yield % (TTM) | 0.7% |
| Forward EPS (USD) | 0.7 |
| Analyst Target Price – Low (USD) | 80 |
| Analyst Target Price – Mean (USD) | 86.4 |
| Analyst Target Price – High (USD) | 100 |
| # Analyst Opinions | 7 |
Source: Yahoo Finance
nLIGHT screens expensive on revenue rather than earnings: EV/revenue is 10.9x and price/sales is 11.9x, while forward P/E is 90.8x on forward EPS of 0.7. I think the market is already pricing a durable shift from losses to scale, not just a one-quarter profit swing, especially with beta at 2.29 and FCF yield at 0.7%. On my read, fair value sits around $18.9-$114.7 per share using peer EV/revenue ranges and the company’s $289.8M of revenue, but that range is wide because the business is still moving from negative EBITDA to a stable earnings base. That range sits broadly around the $80-$100 analyst target band from seven opinions, which tells me consensus is also looking for execution to continue rather than assuming it is already complete. Forward EPS of 0.7 is still far below the peer set, so the stock is being valued on a much steeper earnings ramp than the comparables. I would keep the valuation at Hold because the balance sheet is clean enough to support the story, but the current multiple already assumes the margin recovery arrives on schedule.
Leverage
LASR — Leverage & Coverage (Quarterly)
| Metric | Value |
|---|---|
| Total Debt/Equity % (mrq) | 8.3 |
| Current Ratio (mrq) | 7.1 |
| Total Debt (mrq, USD Mil) | 35.6 |
| Operating Cash Flow (TTM, USD Mil) | 31 |
| Levered Free Cash Flow (TTM, USD Mil) | 24.2 |
| Net Debt/EBITDA (TTM) | 280.2 |
| FCF Margin % (TTM) | 8.3% |
Source: Yahoo Finance — Quarterly Financial Statements
Total debt/equity was 8.3%, current ratio was 7.1, and total debt was $35.6M, so the balance sheet is not the constraint. Operating cash flow was $31M TTM and levered free cash flow was $24.2M TTM, which gives the company room to fund working capital and absorb a softer quarter. FCF margin was 8.3%, a solid cash conversion rate, but net debt/EBITDA of 280.2x is a reminder that the real issue is weak EBITDA, not heavy borrowing. In other words, the company is liquid today, yet the leverage profile only improves if earnings keep moving higher.
Comparable Analysis
Growth
| Company | Revenue TTM (USD Mil) | Revenue Growth YoY % | EBITDA TTM (USD Mil) | Diluted EPS TTM |
|---|---|---|---|---|
| LASR | 289.8 | 55.2% | -1.1 | -0.3 |
| LITE | 2,488.4 | 90.1% | 508.8 | 5.7 |
| IPGP | 1,041.5 | 16.6% | 91.8 | 0.7 |
| COHR | 6,602.1 | 20.5% | 1,313.7 | 2.1 |
| NVMI | 902.5 | 10.3% | 283.9 | 8 |
| ONTO | 1,030.6 | 9.5% | 266.9 | 2.1 |
Source: Yahoo Finance
LASR’s revenue growth of 55.2% TTM is well ahead of ONTO at 9.5%, NVMI at 10.3%, IPGP at 16.6%, and COHR at 20.5%, so the market is paying for a much faster top-line ramp. That said, LASR’s EBITDA is still $-1.1M TTM and diluted EPS is -0.3, while NVMI already converts 10.3% growth into $283.9M of EBITDA and COHR turns 20.5% growth into $1.3B, which shows LASR is earlier in the earnings conversion curve than the peers it is being compared with.
Valuation
| Company | Forward P/E | EV/Revenue | EV/EBITDA | Price/Sales (TTM) | Price/Book (mrq) | Market Cap (USD Mil) | Enterprise Value (USD Mil) | Beta (5Y Monthly) | FCF Yield % (TTM) | Forward EPS | Analyst Target Price – Low | Analyst Target Price – Mean | Analyst Target Price – High | # Analyst Opinions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LASR | 90.8 | 10.9 | -2,985.7 | 11.9 | 8.1 | 3,462 | 3,165 | 2.29 | 0.7% | 0.7 | 80 | 86.4 | 100 | 7 |
| LITE | 45.1 | 23.6 | 115.4 | 25.5 | 19.7 | 63,561 | 58,719 | 1.48 | 0.1% | 18.1 | 600 | 1,111.3 | 1,400 | 25 |
| IPGP | 46.4 | 3.6 | 40.9 | 4.4 | 2.2 | 4,550 | 3,753 | 0.95 | 0.0% | 2.3 | 92.5 | 130.5 | 160 | 7 |
| COHR | 46.5 | 11.5 | 57.7 | 11.3 | 7 | 74,452 | 75,793 | 2.05 | -0.3% | 8.2 | 230 | 384.5 | 465 | 22 |
| NVMI | 37.8 | 16.9 | 53.7 | 17.2 | 11.8 | 15,540 | 15,234 | 1.75 | 0.8% | 12.9 | 494 | 597.6 | 640 | 8 |
| ONTO | 32.6 | 15 | 57.9 | 15.6 | 7.7 | 16,113 | 15,459 | 1.62 | 1.2% | 9.9 | 330 | 363.6 | 450 | 10 |
Source: Yahoo Finance
LASR’s FCF yield of 0.7% TTM is below ONTO at 1.2%, NVMI at 0.8%, and LITE at 3.8%, so the stock is not cheap on cash generation even before you get to the 10.9x EV/revenue multiple. On forward EPS, LASR at 0.7 is far below ONTO at 9.9, NVMI at 12.9, IPGP at 2.3, and COHR at 8.2, which tells me the current share price is already discounting a sharp earnings step-up. The valuation premium is therefore tied to execution, not to current profitability, and that is why I would not call it a bargain on a growth-adjusted basis.
Profitability
| Company | Operating Margin (TTM) | Net Margin (TTM) | Return on Assets (TTM) | Return on Equity (TTM) | Gross Margin (TTM) | EBITDA Margin (TTM) |
|---|---|---|---|---|---|---|
| LASR | -0.5% | -5.1% | -2.3% | -4.6% | 31.3% | -0.4% |
| LITE | 21.8% | 17.7% | 2.9% | 22.8% | 40.8% | 20.4% |
| IPGP | 2.1% | 2.8% | 0.6% | 1.4% | 37.6% | 8.8% |
| COHR | 13.6% | 7.1% | 3.1% | 4.7% | 37.0% | 19.9% |
| NVMI | 30.1% | 29.2% | 8.4% | 22.3% | 57.3% | 31.4% |
| ONTO | 16.8% | 10.3% | 5.4% | 5.3% | 54.2% | 25.9% |
Source: Yahoo Finance
LASR’s gross margin of 31.3% is below IPGP at 37.6%, COHR at 37.0%, ONTO at 54.2%, and NVMI at 57.3%, while EBITDA margin of -0.4% trails every profitable peer in the set. ROE of -4.6% and ROA of -2.3% also lag the group, which tells me the company is still converting its revenue base into earnings less efficiently than the peers that already have scale. The gap matters because the moat has to show up in margins before it can justify a premium multiple.
Leverage
| Company | Total Debt/Equity % (mrq) | Current Ratio (mrq) | Total Debt (mrq, USD Mil) | Operating Cash Flow TTM (USD Mil) | Free Cash Flow TTM (USD Mil) | Net Debt/EBITDA (TTM) | FCF Margin % (TTM) |
|---|---|---|---|---|---|---|---|
| LASR | 8.3 | 7.1 | 35.6 | 31 | 24.2 | 280.2 | 8.3% |
| LITE | 111.4 | 1.1 | 3,313.7 | 452.4 | 93.3 | 0.3 | 3.8% |
| IPGP | 0.8 | 5.8 | 16.3 | 56.4 | 0.6 | -8.7 | 0.1% |
| COHR | 31.1 | 3 | 3,425.1 | 140.3 | -197.6 | 0.8 | -3.0% |
| NVMI | 57.7 | 1.6 | 800.2 | 217.1 | 122.4 | -1.1 | 13.6% |
| ONTO | — | 6.2 | 0 | 262.7 | 197.2 | -2.5 | 19.1% |
Source: Yahoo Finance
LASR’s debt/equity of 8.3% is cleaner than COHR at 31.1%, NVMI at 57.7%, and LITE at 111.4%, but the more important read is current ratio at 7.1 versus 1.1 for LITE and 1.6 for NVMI. That liquidity cushion helps explain why LASR can keep investing through the earnings transition, even though net debt/EBITDA of 280.2x is distorted by negative EBITDA and should not be read as conventional leverage. Compared with peers, the balance sheet is a support, not the source of the valuation premium.
Conclusion
I would put my rating as a Hold because the business is finally showing operating leverage, but the valuation already assumes that improvement keeps compounding. Q1 2026 EBITDA turned positive at $4.4M and revenue held above $80M, which is encouraging, yet TTM operating margin is still -0.5% and FCF yield is only 0.7%, so the company has not yet proven to me that the recent step-up is fully durable.
I would raise my rating more toward a Buy if revenue stays above $80M for two more quarters and operating margin turns positive, meaning the core business is covering fixed costs rather than relying on one strong quarter. I would also want EBITDA to stay positive for two straight quarters, because that would show the Q1 print was not a one-off and that the Aerospace and Defense mix is translating into repeatable cash generation. On the downside, I would move from Hold to Sell if revenue falls back below $65M for two consecutive quarters or if operating margin slips deeper than -53.0%, because that would tell me the recent acceleration was timing-driven rather than demand-driven.
Weighing both paths, I think the bull case is more likely to show up first, but not fast enough to justify a Buy today. The stock has already rerated sharply, with a 211.8% 52-week gain, so I want one more clean quarter of profit conversion before I become more constructive.
What’s your take? I rated nLIGHT (LASR) HOLD above — but the goal here is to get this right, not just to publish an opinion. What would you add to this analysis, or which risk or catalyst do you think I’m under- or over-weighting? Tell me in the comments.
Data sourced from Yahoo Finance. Not investment advice.
Leave a Reply